SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-034060
Filing Date
2023-12-11
Accepted
2023-12-11 08:55:27
Documents
27
Period of Report
2023-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20231128_8k.htm   iXBRL 8-K 28709
2 EXHIBIT 99.1 ex_600778.htm EX-99.1 7442
7 pic1.jpg GRAPHIC 7672
8 pic01.jpg GRAPHIC 126838
9 pic02.jpg GRAPHIC 145805
10 pic03.jpg GRAPHIC 127545
11 pic04.jpg GRAPHIC 96729
12 pic05.jpg GRAPHIC 86937
13 pic06.jpg GRAPHIC 110086
14 pic07.jpg GRAPHIC 83000
15 pic08.jpg GRAPHIC 117364
16 pic09.jpg GRAPHIC 96704
17 pic10.jpg GRAPHIC 121187
18 pic11.jpg GRAPHIC 68867
19 pic12.jpg GRAPHIC 127595
  Complete submission text file 0001437749-23-034060.txt   1992423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20231211.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20231211_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20231211_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20231211_pre.xml EX-101.PRE 11585
21 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20231128_8k_htm.xml XML 2560
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 231477023
SIC: 2834 Pharmaceutical Preparations